• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症新型冠状病毒肺炎年轻成人患者的临床特征及死亡预测因素:一项回顾性观察研究

Clinical characteristics and predictors of mortality in young adults with severe COVID-19: a retrospective observational study.

作者信息

Lu Yanjiao, Huang Zhenli, Wang Meijia, Tang Kun, Wang Shanshan, Gao Pengfei, Xie Jungang, Wang Tao, Zhao Jianping

机构信息

Department of Respiratory and Critical Care Medicine, National Clinical Research Center of Respiratory Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Henan University of Science and Technology, Luoyang, 471003, China.

出版信息

Ann Clin Microbiol Antimicrob. 2021 Jan 6;20(1):3. doi: 10.1186/s12941-020-00412-9.

DOI:10.1186/s12941-020-00412-9
PMID:33407543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7787410/
Abstract

BACKGROUND AND OBJECTIVE

Little is yet known whether pathogenesis of COVID-19 is different between young and elder patients. Our study aimed to investigate the clinical characteristics and provide predictors of mortality for young adults with severe COVID-19.

METHODS

A total of 77 young adults with confirmed severe COVID-19 were recruited retrospectively at Tongji Hospital. Clinical characteristics, laboratory findings, treatment and outcomes were obtained from electronic medical records. The prognostic effects of variables were analyzed using logistic regression model.

RESULTS

In this retrospective cohort, non-survivors showed higher incidence of dyspnea and co-existing laboratory abnormalities, compared with young survivals in severe COVID-19. Multivariate logistic regression analysis showed that lymphopenia, elevated level of d-dimer, hypersensitive cardiac troponin I (hs-CTnI) and high sensitivity C-reactive protein (hs-CRP) were independent predictors of mortality in young adults with severe COVID-19. Further analysis showed that severely young adults with two or more factors abnormalities above would be more prone to death. The similar predictive effect of above four factors had been observed in all-age patients with severe COVID-19.

CONCLUSION

Lymphopenia, elevated level of d-dimer, hs-CTnI and hs-CRP predicted clinical outcomes of young adults with severe COVID-19.

摘要

背景与目的

关于新型冠状病毒肺炎(COVID-19)在年轻和老年患者中的发病机制是否存在差异,目前所知甚少。我们的研究旨在调查重症COVID-19年轻成人患者的临床特征,并提供死亡率的预测指标。

方法

回顾性招募了77例确诊为重症COVID-19的年轻成人患者,这些患者均来自同济医院。从电子病历中获取临床特征、实验室检查结果、治疗情况及预后。采用逻辑回归模型分析各变量的预后影响。

结果

在这个回顾性队列研究中,与重症COVID-19年轻幸存者相比,非幸存者呼吸困难及合并实验室异常的发生率更高。多因素逻辑回归分析显示,淋巴细胞减少、D-二聚体水平升高、超敏心肌肌钙蛋白I(hs-CTnI)及高敏C反应蛋白(hs-CRP)升高是重症COVID-19年轻成人患者死亡的独立预测因素。进一步分析表明,上述两项或更多因素异常的重症年轻成人患者更容易死亡。在所有年龄段的重症COVID-19患者中均观察到上述四个因素具有相似的预测作用。

结论

淋巴细胞减少、D-二聚体水平升高、hs-CTnI及hs-CRP可预测重症COVID-19年轻成人患者的临床预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1edc/7788921/3860dc4e35f2/12941_2020_412_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1edc/7788921/3860dc4e35f2/12941_2020_412_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1edc/7788921/3860dc4e35f2/12941_2020_412_Fig1_HTML.jpg

相似文献

1
Clinical characteristics and predictors of mortality in young adults with severe COVID-19: a retrospective observational study.重症新型冠状病毒肺炎年轻成人患者的临床特征及死亡预测因素:一项回顾性观察研究
Ann Clin Microbiol Antimicrob. 2021 Jan 6;20(1):3. doi: 10.1186/s12941-020-00412-9.
2
Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19.与 COVID-19 患者急性心脏损伤相关的因素及其对死亡率的影响。
Sci Rep. 2020 Nov 24;10(1):20452. doi: 10.1038/s41598-020-77172-1.
3
Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China.中国新冠肺炎疫情早期单中心回顾性研究:糖尿病合并 COVID-19 患者不良预后的危险因素。
Front Endocrinol (Lausanne). 2020 Sep 24;11:571037. doi: 10.3389/fendo.2020.571037. eCollection 2020.
4
Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.在住院的 COVID-19 患者中,心脏损伤、炎症和凝血生物标志物与结局的纵向相关性。
J Mol Cell Cardiol. 2020 Oct;147:74-87. doi: 10.1016/j.yjmcc.2020.08.008. Epub 2020 Aug 20.
5
Predictive factors of severe coronavirus disease 2019 in previously healthy young adults: a single-center, retrospective study.先前健康的年轻成年人中严重 2019 冠状病毒病的预测因素:一项单中心回顾性研究。
Respir Res. 2020 Jun 22;21(1):157. doi: 10.1186/s12931-020-01412-1.
6
Predictors of fatality including radiographic findings in adults with COVID-19.COVID-19 成人患者病死率的预测因素包括影像学表现。
Respir Res. 2020 Jun 11;21(1):146. doi: 10.1186/s12931-020-01411-2.
7
Clinical characteristics and risk factors for in-hospital mortality of lung cancer patients with COVID-19: A multicenter, retrospective, cohort study.COVID-19 肺癌患者住院死亡率的临床特征和危险因素:一项多中心、回顾性、队列研究。
Thorac Cancer. 2021 Jan;12(1):57-65. doi: 10.1111/1759-7714.13710. Epub 2020 Nov 3.
8
Clinical characteristics and the risk factors for severe events of elderly coronavirus disease 2019 patients.2019年冠状病毒病老年患者的临床特征及严重事件的危险因素
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):542-548. doi: 10.11817/j.issn.1672-7347.2020.200292.
9
Cardiac Troponin I association with critical illness and death risk in 726 seriously ill COVID-19 patients: A retrospective cohort study.726例重症COVID-19患者中心脏肌钙蛋白I与危重病和死亡风险的关联:一项回顾性队列研究
Int J Med Sci. 2021 Jan 29;18(6):1474-1483. doi: 10.7150/ijms.53641. eCollection 2021.
10
Association of coagulation dysfunction with cardiac injury among hospitalized patients with COVID-19.COVID-19 住院患者凝血功能障碍与心脏损伤的相关性。
Sci Rep. 2021 Feb 24;11(1):4432. doi: 10.1038/s41598-021-83822-9.

引用本文的文献

1
Clinical Characteristics and Risk Factors for Mortality in Critical COVID-19 Patients Aged 50 Years or Younger During Omicron Wave in Korea: Comparison With Patients Older Than 50 Years of Age.韩国奥密克戎变异株流行期间 50 岁及以下危重症 COVID-19 患者的临床特征及死亡危险因素:与 50 岁以上患者的比较。
J Korean Med Sci. 2023 Jul 17;38(28):e217. doi: 10.3346/jkms.2023.38.e217.
2
Predictors of Mortality in COVID-19 patients: An observational study.新冠病毒肺炎患者死亡的预测因素:一项观察性研究。
Pak J Med Sci. 2023 Jan-Feb;39(1):241-247. doi: 10.12669/pjms.39.1.6059.
3
Blood phenotype O and indirect bilirubin are associated with lower, early COVID-19-related mortality: A retrospective study.

本文引用的文献

1
Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China.中国上海 333 例新冠肺炎确诊病例的流行病学和临床特征。
Transbound Emerg Dis. 2020 Jul;67(4):1697-1707. doi: 10.1111/tbed.13604. Epub 2020 May 13.
2
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.中性粒细胞与淋巴细胞比值、动态中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在 COVID-19 患者中的诊断及预测作用。
Int Immunopharmacol. 2020 Jul;84:106504. doi: 10.1016/j.intimp.2020.106504. Epub 2020 Apr 13.
3
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China.
血 phenotype O 与间接胆红素与较低的 COVID-19 相关早期死亡率相关:一项回顾性研究。
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221133952. doi: 10.1177/03946320221133952.
4
COVID-19 Severity and Mortality in Two Pandemic Waves in Poland and Predictors of Poor Outcomes of SARS-CoV-2 Infection in Hospitalized Young Adults.波兰两波疫情期间新冠病毒疾病的严重程度和死亡率以及住院青年成人感染新冠病毒不良预后的预测因素
Viruses. 2022 Jul 31;14(8):1700. doi: 10.3390/v14081700.
5
Clinical Characteristics and Risk Factors for Mortality in Critical Coronavirus Disease 2019 Patients 50 Years of Age or Younger During the Delta Wave: Comparison With Patients > 50 Years in Korea.德尔塔变异株流行期间 50 岁及以下危重新冠肺炎患者的临床特征和死亡危险因素:与韩国 > 50 岁患者的比较
J Korean Med Sci. 2022 Jun 6;37(22):e175. doi: 10.3346/jkms.2022.37.e175.
6
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.研究2019冠状病毒病重症和死亡风险因素的研究中的异质性和偏倚风险:一项系统评价和荟萃分析
Pathogens. 2022 May 10;11(5):563. doi: 10.3390/pathogens11050563.
7
Decoding clinical biomarker space of COVID-19: Exploring matrix factorization-based feature selection methods.解析 COVID-19 的临床生物标志物空间:探索基于矩阵分解的特征选择方法。
Comput Biol Med. 2022 Jul;146:105426. doi: 10.1016/j.compbiomed.2022.105426. Epub 2022 Apr 5.
8
Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.伊朗克尔曼沙阿省 27256 例住院 COVID-19 患者的人口统计学、临床特征和结局:一项回顾性一年队列研究。
BMC Infect Dis. 2022 Mar 31;22(1):319. doi: 10.1186/s12879-022-07312-7.
9
Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis.严重和致命 COVID-19 感染患者免疫功能障碍的代表性参数的识别:系统评价和荟萃分析。
Clin Rev Allergy Immunol. 2023 Feb;64(1):33-65. doi: 10.1007/s12016-021-08908-8. Epub 2022 Jan 18.
10
Subclinical myocardial injury, coagulopathy, and inflammation in COVID-19: A meta-analysis of 41,013 hospitalized patients.新型冠状病毒肺炎中的亚临床心肌损伤、凝血病和炎症:对41013例住院患者的荟萃分析
Int J Cardiol Heart Vasc. 2022 Jun;40:100950. doi: 10.1016/j.ijcha.2021.100950. Epub 2022 Jan 4.
中国全国范围内分析的 2019 年冠状病毒病住院患者死亡结局的危险因素。
Chest. 2020 Jul;158(1):97-105. doi: 10.1016/j.chest.2020.04.010. Epub 2020 Apr 15.
4
Clinical Characteristics and Outcomes of Older Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective Study.中国武汉 COVID-19 老年患者的临床特征和结局:一项单中心回顾性研究。
J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1788-1795. doi: 10.1093/gerona/glaa089.
5
A Comparative Study of Chest Computed Tomography Features in Young and Older Adults With Corona Virus Disease (COVID-19).中青年与老年新型冠状病毒肺炎患者胸部 CT 特征的比较研究。
J Thorac Imaging. 2020 Jul;35(4):W97-W101. doi: 10.1097/RTI.0000000000000513.
6
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).COVID-19 患者的致命结局对心血管的影响。
JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017.
7
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
8
Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients.老年 COVID-19 患者的临床特征:与中青年患者的比较。
J Infect. 2020 Jun;80(6):e14-e18. doi: 10.1016/j.jinf.2020.03.005. Epub 2020 Mar 27.
9
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
10
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.单细胞 RNA 测序数据分析受体 ACE2 的表达揭示了不同人体器官易感染 2019-nCoV 的潜在风险。
Front Med. 2020 Apr;14(2):185-192. doi: 10.1007/s11684-020-0754-0. Epub 2020 Mar 12.